Mechanisms contributing to anemia in these patients include deficiency of erythropoietin (EPO), a hormone that is produced in kidneys and to a lesser extent in the liver that supports normal red blood cell production, uremia‐induced inhibition of hematopoiesis, shortened erythrocyte survival, and disordered iron metabolism.1 This evidence concerns the gene EPO and anemia.